News
-
-
-
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: BayWa AG: Impairment tests lead to extraordinary depreciation of € 222.2 million (impairment tests in accordance with IAS 36)
BayWa AG reports non-cash impairment losses of €222.2 million in Half-Year Financial Statements 2024 due to impairment tests. BayWa r.e. AG is the most affected subsidiary -